Efficacy and Safety of Intensified vs Standard Prophylactic Anticoagulation Therapy in Patients Hospitalized With Coronavirus Disease 2019: Updated Systematic Review and Meta-analysis.
Efficacy and Safety of Intensified vs Standard Prophylactic Anticoagulation Therapy in Patients Hospitalized With Coronavirus Disease 2019: Updated Systematic Review and Meta-analysis.
复制标题
DOI:
10.1093/ofid/ofad506
复制
发表时间:
2023-11
影响因子:
4.2
通讯作者:
Eikelboom, John W.
中科院分区:
文献类型:
--
作者:
Scheier, Thomas C.;Carlin, Stephanie;Wills, Nicola K.;Wasserman, Sean;Mertz, Dominik;Eikelboom, John W.
Patient consent statement. The study does not include factors necessitating patient consent. Financial support. SC received speaker fees from BMS/Pfizer and Leo Pharma and advisory board fees from AstraZeneca, and Servier. SW is supported by the National Institutes of Health (K43TW011421 and U01AI170426). JWE received honoraria and/or grants from Anthos, Bayer, BI, BMS, Daiichi-Sankyo, Ionis, Janssen, Merck, Pfizer, and USV.
登录
查看更多内容
影响因子:
24
作者:
Stone, Gregg W.;Farkouh, Michael E.;Lala, Anuradha;Tinuoye, Elizabeth;Dressler, Ovidiu;Moreno, Pedro R.;Palacios, Igor F.;Goodman, Shaun G.;Esper, Rodrigo B.;Abizaid, Alexandre;Varade, Deepak;Betancur, Juan F.;Ricalde, Alejandro;Payro, Gerardo;Castellano, Jose Maria;Hung, Ivan F. N.;Nadkarni, Girish N.;Giustino, Gennaro;Godoy, Lucas C.;Feinman, Jason;Camaj, Anton;Bienstock, Solomon W.;Furtado, Remo H. M.;Granada, Carlos;Bustamante, Jessica;Peyra, Carlos;Contreras, Johanna;Owen, Ruth;Bhatt, Deepak L.;Pocock, Stuart J.;Fuster, Valentin
通讯作者:
Fuster, Valentin
影响因子:
5.2
作者:
Balduzzi, Sara;Ruecker, Gerta;Schwarzer, Guido
通讯作者:
Schwarzer, Guido
影响因子:
37.8
作者:
Bohula, Erin A.;Berg, David D.;Morrow, David A.
通讯作者:
Morrow, David A.
影响因子:
105.7
作者:
Higgins, JPT;Thompson, SG;Altman, DG
通讯作者:
Altman, DG
影响因子:
5.5
作者:
Morici, Nuccia;Podda, GianMarco;Cattaneo, Marco
通讯作者:
Cattaneo, Marco